Barclays lowered the firm’s price target on Sanofi to EUR 95 from EUR 115 and keeps an Overweight rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SNY:
- Sanofi price target lowered to EUR 80 from EUR 90 at Deutsche Bank
- MeiraGTx (NASDAQ:MGTX) Surges After Sanofi’s $30 Million Investment
- MeiraGTx announces $30M strategic investment from Sanofi
- Sanofi price target lowered to EUR 122 at BofA, says selloff ‘hugely overdone’
- Sanofi downgraded to Hold from Buy at Stifel